Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinase type M2 (Tu M2-PK)

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2583-2590

  Wechsel, H W ^a,b   Petri, E ^a   Bichler, K H ^a   Feil, G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Reinhard Nieter Krankenhaus Stadtische Kliniken gGmbH   (Germany)

Author keywords

Pyruvate kinase; Renal cell carcinoma; Tumor marker

Indexed keywords

ISOENZYME; MONOCLONAL ANTIBODY; PHOSPHOENOLPYRUVATE; PYRUVATE KINASE;

BLOOD; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY VEIN; PRIORITY JOURNAL; SERUM; WOUND HEALING;

ANTIBODIES, MONOCLONAL; CARCINOMA, RENAL CELL; CIRCADIAN RHYTHM; DIMERIZATION; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KIDNEY; KIDNEY NEOPLASMS; PYRUVATE KINASE; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 0032781574     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Eigenbrodt E, Reinacher M, Scheefers-Borchel U, Scheefers H and Friis RR: Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. In: Critical Reviews in Oncogenesis, Vol. 3 (Perucho, M, ed.) C.RC-Press, Boca Raton, Florida, pp. 91-11, 1992.
2. Staal GEJ, and Rijksen G: Pyruvate kinase in selected human tumors. In Biochemical and Molecular Aspects of Selected Cancers, Vol. 1 (Pretlow II. T. G, and Pretlow, T.P, ed Academic Press, Inc, San Diego, pp. 313-337.
3. Brink U, Eigenbrodt E, Oehmke M, Mazurek S, Fischer G: L- and M2-pyruvate kinase expression in renal cell carcinoma and their metastases. Virchows Archiv 424: 177-185, 1994.
4. Steinberg P, Storkel S, Oesch F and Thoenes W: Carbohydrate metabolism in human renal clear cell carcinomas. Lab Invest 67: 506-511, 1992.
5. Netzker R, Greiner E, Eigenbrodt E, Noguchi T, Tanaka T and Brand B: Cell cycle-associated expression of M2-type isozyme of pyruvate kinase in proliferating ral thymocytes. J Biol Chem 267: 6421-6424, 1992.
6. Board M, Humm S, and Newsholme A: Maximum activites of key enzymes nf glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem 265: 503-509, 1990.
7. Eigenbrodt M, Reinacher Z, Scheefers-Borchel, Scheefers H, Friis R: Double Role for Pyruvate Kinase 7ype M2 in the Expansion of Phosphometabilite Pools Found in Tumor Cells. Critical Revies in Oncogenesis 3: 91-115, 1992.
8. 2 by glucose is mediated via frucrose 1,6-bisphosphate. J Biol Chem 266: 16812-16846, 1992.
9. Mazurek S, Michel A and Eigenbrod E: Effect of extracellular AMP on cell proliJeration and metabolism of breast cancer cell lines with high and low glycolytic rares. J Biol Chem 272: 4941-4952, 1997.
10. Presek P, Reinacher M, and Eigenbrodt E: Pymvate hnase type M, is phosphorylated at yrosine residues in cells transformed by Rous sarcoma virus. FEBS Lett 242: 194-198, 1988.
11. Oude Weernink PA, Rijksen G and Staal GEJ: Phosphorylation of pyruvate kinase and glycolytic metabolism in three human glioma cell lines. Tumor Biol 12: 339-352, 1991.
12. Lyon RC, Cohen JS, Faustino PJ, Megnin F and Myers CE: Clucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monirored by magnetic resonance spectroscopy. Cancer Res 48: 870-877, 1988.
13. Steen RG: Response to tumors to chemotherapy monitored by in vivo 31p nuclear magnetic resonance spectroscopy. A rewew. Cancer Res 49: 4075-4085, 1989.
14. Robson CJ, Churchill B, Anderson W: The resulls of radical nephrectomy for renal cell carcinoma. J Urol 101: 297, 1969.
15. Scheefers-Borchel U, Scheefers H, Michel A, Will H, Fischer G, Basenau D, Dahlmann N, Laumen R, Mazurek S, and Eigenbrodt E: Quanritative determination (ELISA) of pyruvate kinase type tumor M2-A new tumor marker. Current Tumor Diagnosis: Applications Clinical Relevance. Research - Trends. ed. R. Klapdor(1994). 365-368.
16. Oremek GM, Seiffert UB and Wagner R: Tu-M2-PK. Ein neuer lilmormarker in der pneumologischen Diagnostik. Atemwegs- und LImgenkrankheiten 7: 340, 1995.
17. Petri E, Feil G, Wechsel HW, Bichler KH: Determination of Pyruvate kinase Type Tumor M2 (TuM2Pk) in human testicular tumors: Potential usage for diagnosis compared with AFP/ß-HCG-measurement. J Urol 5: 546A, 1996.